Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
59.75
-0.82 (-1.35%)
At close: Oct 16, 2026, 4:00 PM EDT
59.92
+0.17 (0.29%)
After-hours: Oct 16, 2026, 7:55 PM EDT
BMY Market Cap
BMY has a market cap or net worth of $122.05 billion as of October 16, 2026. It is the 177th most valuable company in the world and the 99th biggest in the United States. Its market cap has increased by 37.12% in one year.
Market Cap
122.05B
Enterprise Value
155.64B
1-Year Change
37.12%
Global Rank
Country Rank
#99 United States
Category
ChartMarket Cap Chart
Since October 18, 2021, BMY's market cap has decreased from $122.59B to $122.05B, a decrease of -0.44%. That is a compound annual growth rate of -0.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 122.01B | 10.69% |
| Dec 31, 2025 | 110.23B | -4.04% |
| Dec 31, 2024 | 114.87B | 10.45% |
| Dec 29, 2023 | 104.01B | -31.43% |
| Dec 30, 2022 | 151.67B | 13.35% |
| Dec 31, 2021 | 133.80B | 9.15% |
| Oct 18, 2021 | 122.59B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AbbVie | 500.94B |
| Merck & Co. | 363.59B |
| Novartis AG | 277.86B |
| AstraZeneca | 250.87B |
| Amgen | 230.37B |
| Gilead Sciences | 190.38B |
| Novo Nordisk | 168.42B |
| Pfizer | 166.49B |